Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMS
- CUSIP Number: n62509109
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frazier Life Sciences Management | 12M | $136M | 0% | Dec 2023 |
|
| Fcpm Iii Services B.v. | 12M | $132M | 100% | Dec 2023 |
|
| Viking Global Investors | 8.0M | $90M | 0% | Dec 2023 |
|
| RA Capital Management | 7.9M | $88M | -13% | Dec 2023 |
|
| Medicxi Ventures Management | 2.9M | $68M | 0% | Mar 2024 |
|
| BVF | 1.5M | $17M | 0% | Dec 2023 |
|
| Goldman Sachs Group | 1.4M | $16M | 100% | Dec 2023 |
|
| GMT Capital Corp | 1.4M | $16M | 0% | Dec 2023 |
|
| Millennium Management | 1.3M | $15M | 27% | Dec 2023 |
|
| Jennison Associates | 931k | $22M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 289k | $3.2M | -13% | Dec 2023 |
|
| Opaleye Management | 265k | $3.0M | 100% | Dec 2023 |
|
| Moody Aldrich Partners | 111k | $2.6M | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 67k | $747k | 3% | Dec 2023 |
|
| Marshall Wace | 34k | $379k | 234% | Dec 2023 |
|
| Yarbrough Capital | 24k | $567k | 100% | Mar 2024 |
|
| HealthInvest Partners AB | 22k | $530k | 100% | Mar 2024 |
|
| Citadel Advisors | 21k | $235k | -33% | Dec 2023 |
|
| Royal Bank of Canada | 11k | $121k | 988% | Dec 2023 |
|
| Venture Visionary Partners | 10k | $112k | 0% | Dec 2023 |
|
| Wolverine Asset Management | 8.7k | $97k | 197% | Dec 2023 |
|
| UBS Group | 800.00 | $8.9k | 100% | Dec 2023 |
|
| Bradley & Co. Private Wealth Management | 729.00 | $17k | 100% | Mar 2024 |
|
| Barclays | 513.00 | $6.0k | 0% | Dec 2023 |
|
| PSI Advisors | 500.00 | $12k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 300.00 | $3.4k | 0% | Dec 2023 |
|
| DuPont Capital Management Corporation | 1.00 | $24.000000 | 0% | Mar 2024 |
|
Who sold out of Newamsterdam Pharma Co Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Henderson Group | Sep 2023 | 435k | $4.0M |
| Maven Securities | Sep 2023 | 25k | $231k |
| Parkwood | Sep 2023 | 20k | $187k |
| Jpmorgan Chase & Co | Sep 2023 | 2.6k | $24k |
| Cutler | Dec 2023 | 500.00 | $5.0k |
| Atticus Wealth Management | Dec 2023 | 100.00 | $1.1k |